• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氢速甾醇-2血清浓度在骨质疏松症和甲状旁腺功能减退症治疗中的应用

Serum concentrations of dihydrotachysterol-2 in the treatment of osteoporosis and hypoparathyroidism.

作者信息

Bosch R, Thijssen J H, Duursma S A

出版信息

Clin Endocrinol (Oxf). 1982 Mar;16(3):295-301. doi: 10.1111/j.1365-2265.1982.tb00719.x.

DOI:10.1111/j.1365-2265.1982.tb00719.x
PMID:7074979
Abstract

A method for the quantitative estimation of dihydrotachysterol-2 is described using high performance liquid chromatography coupled to an UV monitor. Since radioactive labelled DHT2 is not available, recovery is based on the assumption that dihydrotachysterol-2 and cholecalciferol behave identically during chromatic procedures. Evidence is presented to support this assumption. In patients treated with DHT2 the serum concentrations of DHT2 rose in proportion to the administered dose.

摘要

描述了一种使用高效液相色谱与紫外监测器联用定量估算二氢速甾醇-2的方法。由于没有放射性标记的二氢速甾醇-2,回收率基于二氢速甾醇-2和胆钙化醇在色谱过程中表现相同的假设。提供了证据来支持这一假设。在用二氢速甾醇-2治疗的患者中,二氢速甾醇-2的血清浓度与给药剂量成比例升高。

相似文献

1
Serum concentrations of dihydrotachysterol-2 in the treatment of osteoporosis and hypoparathyroidism.二氢速甾醇-2血清浓度在骨质疏松症和甲状旁腺功能减退症治疗中的应用
Clin Endocrinol (Oxf). 1982 Mar;16(3):295-301. doi: 10.1111/j.1365-2265.1982.tb00719.x.
2
[Clinical effects of 1 alpha-hydroxycholecalciferol (alpha-D3) in hypoparathyroidism--comparison with dihydrotachysterol (DHT2)--multi-institutional double blind studies].1α-羟胆钙化醇(α-D3)治疗甲状旁腺功能减退症的临床效果——与双氢速甾醇(DHT2)的比较——多机构双盲研究
Horumon To Rinsho. 1979 Jan;27(1):99-113.
3
Serum dihydrotachysterol levels and biological action in normal man.正常人血清二氢速甾醇水平及其生物学作用
J Clin Endocrinol Metab. 1988 Jul;67(1):198-202. doi: 10.1210/jcem-67-1-198.
4
In vivo dihydrotachysterol2 metabolism in normal man: 1 alpha- and 1 beta-hydroxylation of 25-hydroxydihydrotachysterol2 and effects on plasma parathyroid hormone and 1 alpha,25-dihydroxyvitamin D3 concentrations.正常人的体内二氢速甾醇2代谢:25-羟基二氢速甾醇2的1α-和1β-羟基化及其对血浆甲状旁腺激素和1α,25-二羟基维生素D3浓度的影响。
J Clin Endocrinol Metab. 1994 Jun;78(6):1481-7. doi: 10.1210/jcem.78.6.8200953.
5
[Treatment of hypoparathyroidism with dihydrotachysterol].[用二氢速甾醇治疗甲状旁腺功能减退症]
Probl Endokrinol (Mosk). 1974 Nov-Dec;20(6):39-42.
6
[Behavior of ultra-filtrable serum calcium in parathyroid insufficiency following dihydrotachysterol administration. Animal experimental studies of a clinical phenomenon].[双氢速甾醇给药后甲状旁腺功能减退时可超滤血清钙的行为。一种临床现象的动物实验研究]
Dtsch Gesundheitsw. 1969 Mar 11;24(8):376-8.
7
Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
Clin Nephrol. 1985 Dec;24(6):292-9.
8
[Dihydrotachysterol in treatment of patients with hypoparathyroidism].
Sov Med. 1977 Jun(6):58-60.
9
[Treatment of hypoparathyroidism with dihydrotachysterol].
Nihon Rinsho. 1972 Feb;30(2):646-51.
10
[Observations in vitamin D and dihydrotachysterol poisoning].[维生素D和二氢速甾醇中毒的观察]
Dtsch Med Wochenschr. 1975 Feb 28;100(9):415-6, 419-23. doi: 10.1055/s-0028-1106230.